Bderlo 150mg Tablet Substitute
by Others
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
by AYUR
by AYUR
by Others
by Others
by Others
by Others
by Others
Composition:
ERLOTINIB-150MG
Uses:
Lung cancer, Pancreatic cancer
Medicinal Benefits:
Bderlo 150mg Tablet is prescribed to the patients dealing with nonsmall cell lung cancer and pancreatic cancer. Cancer of this type tends to spread quickly in other parts of the body. Bderlo 150mg Tablet travel through the bloodstream and effectively destroy cancerous cells of the lung, pancreas, and other body parts. Bderlo 150mg Tablet contains Erlotinib is a 'tyrosine kinase inhibitor (TKI)' that stops the uncontrolled growth and spread of cancerous cells. It acts by blocking the abnormal protein's action that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed, it undergoes a usual process of maturity. Cancerous cells form new cells more quickly, so Bderlo 150mg Tablet targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). It also decreases the blood supply to cancer tumors to slow down the growth of the tumor. In this way, Bderlo 150mg Tablet stops the production, spread, and growth of cancerous cells in the body.